Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Aurinia Pharmaceuticals Inc, 3 years.
Aurinia Pharmaceuticals Inc
Director
Skye Bioscience Inc.
Director
Context Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Context Therapeutics Inc. June 24, 202699.9%
-
Skye Bioscience Inc. May 26, 202695.1%
-
Skye Bioscience Inc. June 6, 202590.9%
-
Aurinia Pharmaceuticals Inc June 14, 202450.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 21, 2024 | Aurinia Pharmaceuticals Inc | Grant or award | +12,135 | — | — |
| Nov 11, 2024 | Aurinia Pharmaceuticals Inc | Open-market sale | −5,241 | $8.43 | $44,182 |
| Nov 8, 2024 | Aurinia Pharmaceuticals Inc | Option exercise | +17,913 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.